| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |